These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy. Seyfarth HJ; Pankau H; Hammerschmidt S; Schauer J; Wirtz H; Winkler J Chest; 2005 Aug; 128(2):709-13. PubMed ID: 16100158 [TBL] [Abstract][Full Text] [Related]
31. Inhalation of repurposed drugs to treat pulmonary hypertension. Gessler T Adv Drug Deliv Rev; 2018 Aug; 133():34-44. PubMed ID: 29886070 [TBL] [Abstract][Full Text] [Related]
32. The role of treprostinil in the management of pulmonary hypertension. Skoro-Sajer N; Lang I Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755 [TBL] [Abstract][Full Text] [Related]
33. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience. Sitbon O; Vonk Noordegraaf A Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28096285 [TBL] [Abstract][Full Text] [Related]
34. What Is the Role of Oral Prostacyclin Pathway Medications in Pulmonary Arterial Hypertension Management? El Yafawi R; Wirth JA Curr Hypertens Rep; 2017 Oct; 19(12):97. PubMed ID: 29071454 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension. He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy? Steele P; Strange G; Wlodarczyk J; Dalton B; Stewart S; Gabbay E; Keogh A BMC Cardiovasc Disord; 2010 Feb; 10():9. PubMed ID: 20170553 [TBL] [Abstract][Full Text] [Related]
37. Experiences with treprostinil in the treatment of pulmonary arterial hypertension. Stream AR; Bull TM Ther Adv Respir Dis; 2012 Oct; 6(5):269-76. PubMed ID: 22868690 [TBL] [Abstract][Full Text] [Related]
39. A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension. Wang S; Yu M; Zheng X; Dong S Drug Deliv; 2018 Nov; 25(1):1898-1909. PubMed ID: 30442035 [TBL] [Abstract][Full Text] [Related]
40. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Hoeper MM; Taha N; Bekjarova A; Gatzke R; Spiekerkoetter E Eur Respir J; 2003 Aug; 22(2):330-4. PubMed ID: 12952269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]